Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dc8e1dbd-3db1-470e-ac1a-6b8f5c5b4fee - samples

ABSTRACT: RNAseq FASTq files of 181 bulk pre-treatment and 14 post-treatment tumors from GO30140 Ph1b group A and F and 177 bulk pre-treatment tumors of IMbrave150 PhIII

PROVIDER: EGAD00001008128 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

6c38dd8d-d0b9-4118-946a-63e4f4fd6f9c - samples

Project description:RNAseq FASTq files from 728 bulk pre-treatment tumors from IMvigor010.

| EGAD00001007575 | EGA

289a561c-a53e-41af-a150-43a78fd6ce74 - samples

Project description:TPM matrices of counts from RNAseq data for IMvigor010 from bulk pre-treatment tumors.

| EGAD00001007653 | EGA

6532d6d6-61da-4665-b403-f5fe8aeb7dff - samples

Project description:WES FASTq files of 76 bulk pre-treatment tumors and 76 matched peripheral blood mononuclear cells from GO30140 group A

| EGAD00001008129 | EGA

Heterogeneity in allospecific T cell function in transplant tolerant hosts determines susceptibility to rejection following infection

Project description:CD4+CD45.1+ TCR75/Rag-/- T cells (TCR75) were adoptively transferred into CD45.2+ B6 hosts either untransplanted and immunized with B/c donor splenocytes i.p. (UnTx+DST) to induce memory, or prior to transplantation of a B/c heart (HTx) in the presence of anti-CD154 (day 0, day 7, day 14) and DST (day 0) to induce tolerance (Tol). A group of tolerant mice were infected with Lm on d30 post-transplantation (Tol+Lm). CD45.1+ TCR75 cells were harvested from the spleen and lymph nodes on d35-37 post-transplantation in all groups, enumerated and subjected to bulk RNAseq.

2023-09-29 | E-MTAB-13333 | biostudies-arrayexpress

4612f446-5e68-4aa3-b9b3-dc4620ae2004 - samples

Project description:RNAseq fastq files from 611 bulk pre-treatment tumors from two indications: metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)

| EGAD00001006960 | EGA

a0f5c8f5-32cb-481a-86ed-aa64c793dc80 - samples

Project description:RNAseq FASTq files from 817 bulk pre-treatment tumors from three indications (mUC, NSCLC and RCC) across three phase II (IMvigor210, POPLAR, IMmotion150) and a phase I (PCD4989g) clinical trials.

| EGAD00001006631 | EGA

Homo sapiens

Project description:RNAseq changes in pre MAPKi treatment and post MAPKi resistance Melanomas

| PRJNA273359 | ENA

7d2d6a00-4f55-493d-938a-abb16d3dc72b - samples

Project description:RNAseq FASTq files from 31 post-treatment tumors from PURE01

| EGAD00001008002 | EGA

46986158-75a7-4bd5-9c84-274e0ec775c0 - samples

Project description:NABUCCO cohort 1 sequencing data. The dataset includes: * Whole exome DNAseq pre-treatment on tumor samples (n=24) matched with blood samples (n=24) * RNAseq pre-treatment on tumor samples (n=18) * RNAseq post-treatment on tumor samples (n=18). Not all pre-treatment samples are linked with pre-treatment samples * High coverage Whole exome DNAseq on pre-treatment tumor samples (n=3) matched with post-treatment metastasized lymph nodes isolated with laser microdissection (n=3) * All samples are labelled with the response phenotype (Complete Responder or Non-Complete Responder)

| EGAD00001006250 | EGA

cac43dcf-f14b-49a8-94bc-3fd5ebf15029 - samples

Project description:RNAseq FASTq files from 44 pre-treatment (Ven-Obi or Clb-Obi) and 44 paired, post-treatment relapsed CD19+ B cells.

| EGAD00001009419 | EGA